US Stock MarketDetailed Quotes

ABT Abbott Laboratories

Watchlist
  • 114.990
  • -0.280-0.24%
Close Dec 27 16:00 ET
  • 114.400
  • -0.590-0.51%
Post 20:01 ET
199.45BMarket Cap34.95P/E (TTM)

About Abbott Laboratories Company

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products. It operates through the following business segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Medical Devices segment includes electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Company Profile

SymbolABT
Company NameAbbott Laboratories
Listing DateJan 1, 1929
Issue Price32.00
Founded1888
CEOMr. Robert B. Ford
MarketNYSE
Employees114000
Fiscal Year Ends12-31
Address100 Abbott Park Road
CityAbbott Park
ProvinceIllinois
CountryUnited States of America
Zip Code60064-6400
Phone1-224-667-6100

Company Executives

  • Name
  • Position
  • Salary
  • Robert B. Ford
  • Chairman of the Board and Chief Executive Officer
  • 23.27M
  • Philip P. Boudreau
  • Senior Vice President, Finance and Chief Financial Officer
  • 3.32M
  • John A. Mccoy, Jr
  • Vice President, Finance, Controller and Principal Accounting Officer
  • --
  • Lisa D. Earnhardt
  • Executive Vice President and Group President, Medical Devices
  • 5.50M
  • Andrea F. Wainer
  • Executive Vice President, Rapid and Molecular Diagnostics
  • --
  • Louis H. Morrone
  • Executive Vice President, Core Diagnostics
  • --
  • Daniel Gesua Sive Salvadori
  • Executive Vice President and Group President, Established Pharmaceuticals and Nutritional Products
  • 5.93M
  • Hubert L. Allen
  • Executive Vice President, General Counsel and Secretary
  • 7.42M
  • Mary K. Moreland
  • Executive Vice President, Human Resources
  • --
  • Patricia P. Gonzalez
  • Independent Director
  • 356.96K
  • Dr. Sally E. Blount, PhD
  • Independent Director
  • 362.60K
  • Michael G. O’Grady
  • Independent Director
  • 283.96K
  • General Darren W. McDew
  • Independent Director
  • 331.19K
  • Michael F. Roman
  • Independent Director
  • 337.96K
  • Daniel J. Starks
  • Independent Director
  • 349.29K
  • Dr. Robert J. Alpern,M.D.
  • Independent Director
  • 441.44K
  • Nancy Mckinstry
  • Lead Independent Director
  • 405.96K
  • John G. Stratton
  • Independent Director
  • 341.96K
  • Claire Babineaux-Fontenot
  • Independent Director
  • 354.96K
  • Michelle A. Kumbier
  • Independent Director
  • 331.96K
Heat List
US
Overall
Symbol
Price
% Chg

No Data